Followers | 662 |
Posts | 84402 |
Boards Moderated | 0 |
Alias Born | 05/25/2008 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, May 30, 2024 9:07:28 PM
Recent SXTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 07:55:21 PM
- 60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results • GlobeNewswire Inc. • 08/14/2024 03:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 02:29:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 04:03:54 PM
- 60 Degrees Pharma Provides University of Kentucky with Right of Reference to ARAKODA® NDA in Support of SJ733 Phase IIb Study • GlobeNewswire Inc. • 08/12/2024 01:12:00 PM
- 60 Degrees Pharmaceuticals, Inc. Announces 1:12 Reverse Stock Split • GlobeNewswire Inc. • 08/06/2024 01:26:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/02/2024 08:15:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 08:15:20 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/26/2024 05:21:07 PM
- 60 Degrees Pharmaceuticals Awarded Contract with U.S. Army for ARAKODA® Supply Chain Upgrade Support • GlobeNewswire Inc. • 07/25/2024 01:02:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/24/2024 09:05:37 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/22/2024 03:23:58 PM
- 60 Degrees Pharmaceuticals Signs Clinical Trial Agreements With All Planned Trial Sites for Tafenoquine Babesiosis Study • GlobeNewswire Inc. • 07/19/2024 12:29:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/19/2024 04:15:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 09:28:43 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/12/2024 09:02:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 07:37:22 PM
- 60 Degrees Pharma Announces IRB Approval of Clinical Study of Tafenoquine for Treatment of Babesiosis in Immunocompromised Patients with Persistent Babesia microti Despite Prior Treatment • GlobeNewswire Inc. • 07/09/2024 10:31:00 AM
- First Patient Enrolled in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis at Tufts Medical Center; First and Only Study of Its Kind • GlobeNewswire Inc. • 06/27/2024 11:59:00 AM
- 60 Degrees Pharmaceuticals Receives FDA Orphan Drug Designation for Tafenoquine for Treatment of Patients with Acute Babesiosis • GlobeNewswire Inc. • 06/11/2024 11:59:00 AM
- Enrollment in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis to Begin at Tufts Medical Center; First Study of Its Kind • GlobeNewswire Inc. • 05/30/2024 11:59:00 AM
- 60 Degrees Pharmaceuticals Funds Babesia spp Testing in Chronic Fatigue Patient Samples in NC State College of Veterinary Medicine Study • GlobeNewswire Inc. • 05/20/2024 11:59:00 AM
- 60 Degrees Pharmaceuticals Announces First Quarter 2024 Results • GlobeNewswire Inc. • 05/15/2024 05:45:03 PM
- 60 Degrees Pharmaceuticals Outlines Upcoming Clinical Trial of Tafenoquine in Babesiosis in Letter to Journal of Infectious Diseases • GlobeNewswire Inc. • 05/08/2024 11:59:00 AM
- 60 Degrees Pharmaceuticals Receives FDA Comments on Tafenoquine-Babesiosis Clinical Trial Protocol; No Material Changes Required • GlobeNewswire Inc. • 05/02/2024 11:59:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM